Garcia-Cuellar et al. recently showed that the CDK9 inhibitors PC585 and PC579 are efficient suppressors of mixed-lineage leukemia proliferation and that CDK9 inhibition increase the survival in a murine mixed-lineage leukemia model15. The gene discussed is CDK9; the disease is leukemia.